Precision Medicine Software

Global Market Trajectory & Analytics

MCP22614

EXECUTIVE ENGAGEMENTS

POOL

1043
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

188
Interactions with Platform & by Email

PARTICIPANTS

42
Unique # Participated

VALIDATIONS

12
Responses Validated*

COMPANIES

34
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2022

TABLES

22

PAGES

89

EDITION

5

PRICE

USD 5600

CODE

MCP22614


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

S M N T

%

VALIDATED RESEARCH *

S M N T

* S = Strong; M = Moderate; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
  

HIGHLIGHTS & REPORT INDEX

Global Precision Medicine Software Market to Reach $2.4 Billion by 2026

Amid the COVID-19 crisis, the global market for Precision Medicine Software estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$2.4 Billion by 2026, growing at a CAGR of 10.1% over the analysis period. On-Premise, one of the segments analyzed in the report, is projected to record a 9.4% CAGR and reach US$1.5 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cloud segment is readjusted to a revised 11.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $390 Million in 2021, While China is Forecast to Reach $480.2 Million by 2026

The Precision Medicine Software market in the U.S. is estimated at US$390 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$480.2 Million by the year 2026 trailing a CAGR of 13.2% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 8.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.

SELECT PLAYERS

2bprecise, LLC; Fabric Genomics, Inc.; Foundation Medicine, Inc.; Gene42, Inc.; Human Longevity, Inc.; Lifeomic Health, LLC; N-Of-One, Inc. (A Subsidiary of Qiagen N.V.); Pieriandx, Inc.; Sophia Genetics Sa; Sunquest Information Systems, Inc.; Syapse, Inc.; Translational Software Inc.

SEGMENTS

» Deployment (On-Premise, Cloud) » Application (Oncology, Pharmacogenomics, Rare Diseases, Other Applications) » End-Use (Healthcare Providers, Research Centers & Academic Institutes, Pharma & Biotech Companies, Other End-Uses)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Precision Medicine Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Precision Medicine Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Precision Medicine Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Research Centers & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Research Centers & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Research Centers & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Pharmacogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Pharmacogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharmacogenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Rare Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Rare Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Rare Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
China Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
China Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Precision Medicine Software by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Precision Medicine Software by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Precision Medicine Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
France Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
France Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Precision Medicine Software by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Precision Medicine Software by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Precision Medicine Software by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
INDIA
India Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
India Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
India Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Precision Medicine Software by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Precision Medicine Software by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Precision Medicine Software by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Precision Medicine Software by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Precision Medicine Software by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Precision Medicine Software by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2012, 2020 & 2027
Total Companies Profiled: 34

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com